Pharmaceutical Excipients Market USD 10.15 billion by the year 2030

The global Pharmaceutical Excipients Market was valued at USD 6.53 billion in 2019 and is expected to reach USD 10.15 billion by the year 2030, at a CAGR of 5.7%. Excipients are those products that do not possess any activity of drugs but facilitates the drug delivery process. The increase in the number of diseases worldwide and the rise in disposable income among the consumers for drugs is the primary factor boosting the growth of the pharmaceutical excipients market.

The problems associated with instability, poor solubility and absorption, and other issues related to the active pharmaceutical ingredients are driving the demand for pharmaceutical excipients. The increased importance of nanotechnology in drugs to improve solubility is enhancing the growth of the market. Increasing outbreak of life threatening diseases and increasing incidences of resistance over traditional treatment plan resulting in increasing number of final production are expected to boost the market growth.

Request a Sample@

The Asia Pacific has obtained significant growth in the market due to government initiatives for clinical trials, research, and development for new drugs, a rise in the patient population in the region, and adaptation to the technological advances, etc. However, the High expenditure cost for the drug development process is the primary restraint to market growth.

The COVID-19 Impact:

The recent outbreak of COVID-19 has reported significant growth in the pharmaceutical excipients market. According to the recent epidemiological estimation the impact of COVID-19 will continue furthermore for some significant time across the globe. Pharmaceutical companies are focused in developing the appropriate and desired treatment drugs. Increasing production of final products in the industry has gained huge demand of excipients required for the formulation. However, it might impact negatively to emerging nations in Asia such as China and India, due to the increased restrictions towards international trade i.e., export or import. However, accepting excipients manufactured in own state has propelled the excipient market growth. Certain bodies are also playing vital role in market impact of COVID-19 outbreak. EXCiPACT updated position paper on COVID-19 (Coronavirus) EXCiPACT asbl is a non-profit organisation that require excipient users to qualify their suppliers based on GMP/GDP audits. It regulates such an independent, high quality, third party Certification Scheme available to pharmaceutical excipient manufacturers and distributors worldwide. Recently Wacker a Germany based company has received Excipient Certification from ExciPACT for its alpha cyclodextrin, beta cyclodextrin, and gamma cyclodextrin. Certain excipients have been established high acceptance for manufacturing drug for COVID-19 treatment for example, Roquette a French companys’ hydroxypropyl beta-cyclodextrins (HPβCD) it acts as functional excipient.

Key Coverage of the Report

  • Region and country-wise assessment from the period 2019-2030. For the study, 2019-2018 has been utilized as historical data, 2019 as the base year, and 2020-2030, has been derived as forecasts
  • Regional Competitors clinical pipeline analysis
  • Demand and Supply GAP Analysis
  • Market share analysis of the key industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments

Salient Trends of the Pharmaceutical Excipients Market

  • Allergan in the year 2019 had launched an artificial tear product Refresh Relieva; it is used to relieve discomfort in eyes due to eye dryness. Refresh Relieva includes carboxymethylcellulose, hyaluronic acid, and glycerin in the formulation. It is designed with a HydroCell technology, Refresh Relieve is free from sodium chloride and is a glycerin-based formulation.
  • Ashland in the year 2019 had introduced new excipients for the pharmaceutical formulation; it included Plasdone S630 Ultra, Benecel XR and XRF and, Viate. Plasdone is an improved and a new version of copovidone specially designed to provide better performance in tablet formulations, hot melt extrusion, and in continuous processing. Benecel XR and XRF have an optimized polymer structure it was developed to make the formulation of safe, effective, and stable oral solid controlled-release dose forms. Viate is designed for parenteral, controlled release drug delivery
  • Glossier in the year 2019 had introduced a new product for skincare known as Futuredew; it is a lightweight consistency serum includes glycerin, squalane, jojoba oil, evening primrose oil, olive oil, grapeseed oil, rosehip oil, hyaluronic acid, rosemary leaf oil and castor seed oil for providing better nourishment to the skin
  • Evonik in the year 2018, had launched a EUDRAGIT FL 30 D-55; it is an advanced combination polymer designed for enteric coatings. It is a Highly-flexible polymer and enables in producing a plasticizer-free formulation. It has a property of combining two pharmacopoeial polymers.

Companies considered and profiled in this market study

Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Evonik Industries AG (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), Croda International (UK). Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France) are the key players in the Pharmaceutical Excipients market


  • Based on the products segment organic chemicals had held the highest share of 42.4% in the year 2019 due to the demand for taste masking in drugs. Products like microcrystalline cellulose and starch are widely used to improve the binding, compression, disintegration, gliding of the tablets.
  • Based on functionality segment fillers and diluents are widely used due to the rising demand for dosage forms like tablets, capsules, and powders, microcrystalline cellulose is the widely used diluent in the pharmaceutical industry
  • Based on formulations segment oral formulations are widely used as it is the most convenient dosage form, it includes dosage forms like tablets, capsules, solutions, suspensions, and emulsion. Oral formulations are have obtained the highest market value of about 2.85 billion in the year 2019
  • Europe in the regional segment has obtained the largest market share of about 46.5% in the year 2019 due to the presence of majority pharmaceutical companies in the region, the importance for generic drugs, biosimilar, and superior pharmaceutical products had increased the demand for novel excipients in the region.

Segments covered in the report

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020-2030 For the purpose of this study, Reports and Data have segmented the Pharmaceutical Excipients Market on the basis of products, functionality, formulations, end use, and region.

Products Outlook (Revenue in Million USD; (2019–2030)

  • Organic Chemicals
    • Oleochemicals
      • Fatty Alcohols
      • Mineral Stearates
      • Glycerin
      • Other Oleochemicals
    • Carbohydrates
      • Sugars
        • Actual Sugars
          • Lactose
          • Sucrose
          • Dextrose (D-Glucose)
        • Sugar Alcohols
          • Mannitol
          • Sorbitol
          • Other Sugar Alcohols
        • Artificial Sweeteners
      • Cellulose
        • Microcrystalline Cellulose
        • Cellulose Ethers
        • CMC and Croscarmellose Sodium
        • Cellulose Esters
      • Starch
        • Modified Starch
        • Dried Starch
        • Converted Starch
      • Petrochemicals
        • Glycols
          • Polyethylene Glycol
          • Propylene Glycol
        • Povidones
        • Mineral Hydrocarbons
          • Petrolatum
          • Mineral Waxes
          • Mineral Oils
        • Acrylic Polymers
        • Other Petrochemicals
      • Proteins
      • Other Organic Chemicals
    • Inorganic Chemicals
      • Calcium Phosphate
      • Metal Oxides
      • Halites
      • Calcium Carbonate
      • Calcium Sulfate
      • Other Inorganic Chemicals
    • Others
      • Pharmaceutical-Grade Water
      • Mucilage

Functionality Outlook (Revenue in Million USD; (2019–2030)

  • Fillers and Diluents
  • Suspending and Viscosity Agents
  • Coating Agents
  • Binders
  • Flavouring Agents and Sweetners
  • Disintegrants
  • Colorants
  • Lubricants and Glidants
  • Preservatives
  • Emulsifying Agents
  • Others

Formulations Outlook (Revenue in Million USD; (2019–2030)

  • Oral Formulations
    • Tablets
    • Capsules
  • Hard Gelatin Capsules
  • Soft Gelatin Capsules
  • Liquid Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Others

End Use Outlook (Revenue in Million USD; (2019–2030)

  • Pharmaceutical companies
  • Chemical companies
  • Others

Regional Outlook (Revenue in Million USD; (2019–2030)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Buy quantitative research Report at discounted price – USD 1500

You can place an order or ask any questions, please feel free to contact | +1 9197 992 333



About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:


Leave a Comment

Your email address will not be published. Required fields are marked *